Xu Stella 4
4 · NextCure, Inc. · Filed Jun 17, 2019
Insider Transaction Report
Form 4
NextCure, Inc.NXTC
Xu Stella
Director
Transactions
- Award
Stock Option (Right to Buy)
2019-06-13+22,000→ 22,000 totalExercise: $15.57Exp: 2029-06-12→ Common Stock (22,000 underlying)
Footnotes (1)
- [F1]The option vests in three equal annual installments beginning on June 13, 2020.